Month: January 2026

VANCOUVER, British Columbia, Jan. 23, 2026 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: B76) is pleased to announce the mobilization of an expanded high-resolution ground gravity survey on its Coyote Target corridor, located in the Athabasca Basin of northern Saskatchewan, Canada. The current program is designed to extend the results of Stallion’s previous ground gravity survey by expanding coverage to the west of the original survey area. Mobilization is commencing, with the objective of identifying additional gravity lows and refining the geometry and continuity of anomalies identified at the margins of the earlier survey. Highlights:The expanded survey aims to identify additional gravity lows associated with interpreted density destruction in the basement rocks, which...

MONTREAL, Jan. 23, 2026 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development” or the “Company“) regrets to report that on January 22, 2026, a contractor working at surface suffered a fatal injury following an isolated incident at the Cariboo Gold Project (the “Project“), located in central British Columbia (“B.C.“), Canada. The Company promptly notified appropriate authorities, and an investigation of the incident is underway. Sean Roosen, Chairman and CEO, stated: “We are deeply saddened by this tragic accident and extend our heartfelt condolences and support to our colleague’s family, friends and coworkers during this difficult time. The health, safety and wellbeing of all employees and contractors working at the Project is our highest...

Data from eight participants continue to support safety and tolerability profile of tegoprubart Mean eGFR increased over the measurement period, from 67.0 mL/min/1.73 m² at 12 months to 74.2 mL/min/1.73 m² at 24 months IRVINE, Calif., Jan. 23, 2026 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that it will present 24-month follow-up data from eight patients enrolled in the Phase 1b trial long-term extension evaluating tegoprubart in kidney transplantation at the American Society of Transplant Surgeons Winter Symposium, taking place January 23–25, 2026, in Scottsdale, Arizona. There were no episodes of biopsy-proven acute rejection, graft loss, death, new-onset diabetes mellitus, or de novo donor-specific antibody formation during the study period. Mean estimated glomerular filtration...

Vancouver, BC, Canada, Jan. 23, 2026 (GLOBE NEWSWIRE) — WestKam Gold Corp. (TSXV:WKG) (the “Company” or “WestKam”) announces that it proposes to undertake an up to $300,000 non-brokered private placement (the “Offering”) of up to 4,285,715 units (the “Units”) to be sold at a price of $0.07 per Unit.  Each Unit will consist of one common share of the Company and one common purchase warrant.  Each warrant will be exercisable for one common share at a price of $0.10 for a period of three years. The Units are being offered to qualified purchasers in reliance upon exemptions from prospectus and registration requirements of applicable securities legislation.  The Company may pay a finder’s fee to eligible finders as permitted under applicable securities laws and TSX Venture Exchange (“TSXV”) policies.  The proceeds received from the...

100 MW GenEco Electrolyzer Units at Galp’s Sines RefineryPlug Power Completes Installation of 100 MW GenEco Electrolyzer Units at Galp’s Sines RefinerySLINGERLANDS, N.Y., Jan. 23, 2026 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, today announced the successful completion of the installation of 100MW of PEM GenEco™ electrolyzers at Galp’s Sines Refinery, marking a major milestone in one of Europe’s largest renewable hydrogen projects. Since the project’s initial announcement in October 2025, with the delivery of the first 10MW GenEco electrolyzer module, all ten arrays (100 MW) have now been delivered and installed on site at the refinery. Commissioning of the electrolyzer systems is expected to begin in the coming months. Once operational,...

LONDON and NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has authorized a single-patient expanded access (compassionate use) Investigational New Drug (IND) application submitted by Pedram Hamrah, MD, at the University of South Florida, for the use of urcosimod (0.05%) in a patient with neuropathic corneal pain. Under the FDA-authorized expanded access (IND 176297), urcosimod is being provided by OKYO Pharma for use in a patient with severe neuropathic corneal pain who has limited therapeutic options and no FDA-approved treatments available. “We are grateful that this...

VANCOUVER, British Columbia, Jan. 23, 2026 (GLOBE NEWSWIRE) — Coppernico Metals Inc. (TSX: COPR, OTCQB: CPPMF, FSE: 9I3) (“Coppernico” or the “Company”), is pleased to announce its participation in the upcoming Vancouver Resource Investment Conference (“VRIC”), taking place on Sunday and Monday, January 25-26, 2026, at the Vancouver Convention Centre (1055 Canada Place, Vancouver). Members of the Coppernico team will be available to meet with investors at Booth #124. On Monday, January 26, 2026, Chair and Chief Executive Officer Ivan Bebek will deliver a 10-minute Corporate Presentation at 1:30 p.m. in Workshop 3. The presentation will provide an overview of Coppernico’s strategy and ongoing progress at its Sombrero copper-gold Project in Peru. Later that day, Mr. Bebek will also participate in the Copper Forecast Panel at 3:50...

Tel Aviv, Israel, Jan. 23, 2026 (GLOBE NEWSWIRE) — Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace expanding into the global homeland security sector through advanced artificial intelligence (“AI”)-driven solutions, today announced its strategic preparations to pursue potential opportunities to support security operations surrounding the 2026 FIFA World Cup (“FIFA World Cup”), the world’s largest global sporting event, to be hosted across Canada, Mexico, and the United States (the “U.S.”). Through its wholly owned subsidiary, KeepZone AI Inc., (“KeepZone”), the Company plans to deliver comprehensive, AI-powered security ecosystems tailored for high-density environments such as stadiums, fan zones and crowded public gatherings...

All amounts are in United States dollars, unless otherwise stated. TORONTO, Jan. 23, 2026 (GLOBE NEWSWIRE) — Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) will host an Investor Day in Toronto on Wednesday, February 4, 2026 during which senior management will provide detailed presentations on the Island Gold District Expansion Study and updated three-year guidance. Topics to be covered include:Three-year guidance and longer-term outlook Island Gold District Expansion Study Development projects update Global exploration updateA live webcast of the presentation will start at 8:30 am ET on February 4, 2026. To view the live webcast, please register at www.alamos2026investorday.com. An on-demand replay will be available within 24 hours at the same link. The webcast will be archived at www.alamosgold.com. About...